Medicare Enrolled

Dr. John Gavini, M.D.

Internal Medicine · Hanford, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1524 W. LACEY BLVD, Hanford, CA 93230
5595834503
In practice since 2006 (19 years)
NPI: 1750328803 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gavini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gavini? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gavini

Dr. John Gavini is an internal medicine specialist in Hanford, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gavini performed 1,991 Medicare services across 912 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gavini received a total of $11,673 from 53 pharmaceutical and/or device companies across 732 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gavini is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 16% volume in CA $11,673 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,991
Medicare services
Top 16% in CA for internal medicine
912
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,130 $90 $158
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
321 $65 $108
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
202 $135 $200
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
123 $96 $220
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
62 $12 $50
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
36 $227 $290
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
34 $118 $239
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
28 $1 $10
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
26 $69 $200
Injection, hydrocortisone sodium succinate, up to 100 mg 15 $13 $50
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $49 $67
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,673
Total received (2018-2024)
Avg $1,668/year across 7 years
Top 9% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
732
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,673 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,363
2023
$1,221
2022
$1,337
2021
$2,152
2020
$1,466
2019
$1,885
2018
$2,249

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$346
Boehringer Ingelheim Pharmaceuticals, Inc.
$180
Amgen Inc.
$158
Mylan Specialty L.P.
$136
Novo Nordisk Inc
$103
ABBVIE INC.
$57
Otsuka America Pharmaceutical, Inc.
$50
IRONWOOD PHARMACEUTICALS, INC
$49
Bayer Healthcare Pharmaceuticals Inc.
$44
Astellas Pharma US Inc
$42
Dexcom, Inc.
$40
PFIZER INC.
$36
GlaxoSmithKline, LLC.
$30
Lilly USA, LLC
$25
Baxter Healthcare
$21
Ardelyx, Inc.
$18
Abbott Laboratories
$15
Merck Sharp & Dohme LLC
$13
Top 3 companies account for 50.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,287
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,031
Novo Nordisk Inc
$933
Amgen Inc.
$720
Janssen Pharmaceuticals, Inc
$511
Mylan Specialty L.P.
$502
Merck Sharp & Dohme Corporation
$426
Lilly USA, LLC
$419
GlaxoSmithKline, LLC.
$418
AbbVie Inc.
$411
Amarin Pharma Inc.
$401
SANOFI-AVENTIS U.S. LLC
$394
ABBVIE INC.
$344
Ironwood Pharmaceuticals, Inc
$291
Astellas Pharma US Inc
$254
PFIZER INC.
$236
Biohaven Pharmaceutical Holding Company Ltd.
$178
Allergan Inc.
$141
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$133
Otsuka America Pharmaceutical, Inc.
$132
Daiichi Sankyo Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$115
IRONWOOD PHARMACEUTICALS, INC
$113
Novartis Pharmaceuticals Corporation
$111
Abbott Laboratories
$103
Biohaven Pharmaceuticals, Inc.
$89
Dexcom, Inc.
$86
Eisai Inc.
$84
Bayer HealthCare Pharmaceuticals Inc.
$57
Baxter Healthcare
$52
Avanir Pharmaceuticals, Inc.
$51
Bayer Healthcare Pharmaceuticals Inc.
$44
Synergy Pharmaceuticals Inc
$41
Sumitomo Pharma America, Inc.
$41
IDORSIA PHARMACEUTICALS US INC
$35
E.R. Squibb & Sons, L.L.C.
$35
Mannkind Corporation
$30
Merck Sharp & Dohme LLC
$28
Sunovion Pharmaceuticals Inc.
$27
Regeneron Healthcare Solutions, Inc.
$26
UROVANT SCIENCES INC
$21
Alexion Pharmaceuticals, Inc.
$18
Philips Electronics North America Corporation
$18
Ardelyx, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$18
Horizon Therapeutics plc
$17
MannKind Corporation
$17
Shire North American Group Inc
$17
Ultragenyx Pharmaceutical Inc.
$16
EISAI INC.
$16
DEXCOM, INC.
$15
Allergan, Inc.
$13
Edwards Lifesciences Corporation
$12
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · ANORO · Aimovig · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · BYDUREON · BYSTOLIC · CHANTIX · COMIRNATY · CREON · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · GEMTESA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Horizant · IBSRELA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · Linzess · MOUNJARO · MYRBETRIQ · Motegrity · NATPARA (PARATHYROID HORMONE) · NUEDEXTA · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · Repatha · Rybelsus · S&RC Und · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Strensiq · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · VERQUVO · VESICARE · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in CA.

Looking for an internal medicine specialist in Hanford?
Compare internal medicine physicians in the Hanford area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
117
Per 100K population
76.6
County median income
$68,750
Nearest hospital
ADVENTIST HEALTH HANFORD
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gavini is a clinical cardiology specialist, with above-average Medicare volume (top 16% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gavini experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gavini performed 1,130 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gavini receive payments from pharmaceutical companies?
Yes. Dr. Gavini received a total of $11,673 from 53 companies across 732 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gavini's costs compare to other internal medicine physicians in Hanford?
Dr. Gavini's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gavini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →